Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Chronic Phase CML Patients

被引：0
|
作者：
Ruppert, Lioba [1 ]
Rinke, Jenny [1 ]
Waldau, Anja [1 ]
Pfirrmann, Markus [2 ]
Hochhaus, Andreas [1 ]
Ernst, Thomas [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Onkol Forschungslab, Jena, Germany
[2] Ludwig Maximilians Univ Munchen, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
486
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [41] Detection of BCR-ABL gene mutations in chronic myeloid leukemia using biochips
    A. Yu. Ikonnikova
    Yu. E. Yatsenko
    O. S. Kremenetskaya
    O. V. Vinogradova
    D. O. Fesenko
    I. S. Abramov
    V. A. Ovsepyan
    T. V. Nasedkina
    Molecular Biology, 2016, 50 : 412 - 416
  • [42] Detection of BCR-ABL Gene Mutations in Chronic Myeloid Leukemia Using Biochips
    Ikonnikova, A. Yu.
    Yatsenko, Yu. E.
    Kremenetskaya, O. S.
    Vinogradova, O. V.
    Fesenko, D. O.
    Abramov, I. S.
    Ovsepyan, V. A.
    Nasedkina, T. V.
    MOLECULAR BIOLOGY, 2016, 50 (03) : 412 - 416
  • [43] The prevalence of mutations in the ATP binding site of bcr-abl among patients with chronic myeloid leukemia.
    Bailey, TJ
    Neppalli, V
    Holman, CJ
    Dolan, M
    Brown, CA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (02) : 284 - 285
  • [44] THE BCR-ABL GENE IN CHRONIC MYELOGENOUS LEUKEMIA
    SAWYERS, CL
    CANCER SURVEYS, 1992, 15 : 37 - 51
  • [45] Modeling BCR-ABL transcript dynamics in CML patients under imatinib treatment.
    Roeder, Ingo
    Horn, Matthias
    Glauche, Ingmar
    Hochhaus, Andreas
    Mueller, Martin C.
    Loeffler, Markus
    BLOOD, 2006, 108 (11) : 611A - 611A
  • [46] Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
    H Pfeifer
    T Lange
    S Wystub
    B Wassmann
    J Maier
    A Binckebanck
    A Giagounidis
    M Stelljes
    M Schmalzing
    U Dührsen
    L Wunderle
    H Serve
    P Brück
    A Schmidt
    D Hoelzer
    O G Ottmann
    Leukemia, 2012, 26 : 1475 - 1481
  • [47] Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
    Pfeifer, H.
    Lange, T.
    Wystub, S.
    Wassmann, B.
    Maier, J.
    Binckebanck, A.
    Giagounidis, A.
    Stelljes, M.
    Schmalzing, M.
    Duehrsen, U.
    Wunderle, L.
    Serve, H.
    Brueck, P.
    Schmidt, A.
    Hoelzer, D.
    Ottmann, O. G.
    LEUKEMIA, 2012, 26 (07) : 1475 - 1481
  • [48] Spectrum of BCR-ABL Kinase Domain Mutations in North Macedonia in Patients With CML Resistant to Imatinib
    Stojanovska-Jakimovska, Simona
    Cvetanoski, Milche
    Ridova, Nevenka
    Trajkova, Sanja
    Popova-Labachevska, Marija
    Mojsovska, Tara
    Dukovski, Dushko
    Pivkova-Veljanovska, Aleksandra
    Stojanovski, Zlate
    Krstevska-Balkanov, Svetlana
    Pavkovic, Marica
    Chadievski, Lazar
    Panovska-Stavridis, Irina
    Ivanovski, Martin
    Gjorgievska, Emilija
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S375 - S375
  • [49] BCR-ABL FUSION TRANSCRIPTS' FREQUENCIES IN SUDANESE CML PATIENTS
    Muddathir, AbdelRahim
    Kordofani, Anwar
    Fadl-Elmula, Imad
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 57 - 57
  • [50] Frequency of BCR-ABL Transcript Types in Syrian CML Patients
    Farhat-Maghribi, Sulaf
    Habbal, Wafa
    Monem, Fawza
    JOURNAL OF ONCOLOGY, 2016, 2016
12345